A recent study led by Tiffany Schmidt, Ph.D., associate professor of Ophthalmology and of Neurobiology in the Weinberg ...

Scientists at Mizzou have identified two small molecules, agmatine and thiamine, that could both reveal and fight glaucoma.

They say beauty lies in the eyes of the beholder, but what happens when the beholder’s eyes are too dry, strained, and glassy ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the ...

Scientists have discovered that two existing pain-relief medications can not only reduce severe tumor-related pain but also ...

Background/Aims The neuroprotective effect of nicotinamide (NAM) supplementation has been demonstrated in both animal models ...

Two mechanisms of structural and functional retinal impairment based on papilledema severity have been identified among ...

The findings could enable earlier detection and treatment for people affected by the serious eye condition. A research team ...

Retinal inner layer thinning detected by OCT offers a promising biomarker for monitoring multiple sclerosis progression.

University of Missouri researchers have discovered two potential biomarkers of glaucoma – agmatine and thiamine ...

From MIGS integration to remote monitoring and next-generation therapeutics, glaucoma specialists explore how new approaches ...

Globally, synovial sarcoma remains a rare but aggressive malignancy with a 5-year survival rate of 70% to 80% and a 10-year ...